
FDA Approves neffy for Treatmet of Type 1 Allergic Reactions, Anaphylaxis
The FDA approved neffy 1 mg, an epinephrine nasal spray, for the treatment of type I allergic reactions, including anaphylaxis, for children 4 years and older who weigh 15 to less than 30 kg. The approval is the first significant innovation for the …